However, we only detected the effects of specific inhibitors on the expression levels of PI3K/Akt/Nrf2 pathway-related proteins but did not determine whether these inhibitors could reverse the neuroprotective effects of EA in vivo and in vitro. This evidence concerns the gene NFE2L2 and Esophageal atresia.